Articles with public access mandates - Andreas BuckLearn more
Not available anywhere: 13
Synthesis and evaluation of a radiometal-labeled macrocyclic chelator-derivatised thymidine analog
M Schmid, B Neumaier, ATJ Vogg, K Wczasek, C Friesen, FM Mottaghy, ...
Nuclear medicine and biology 33 (3), 359-366, 2006
Mandates: German Research Foundation
A rapid ex vivo tissue model for optimising drug detection and ionisation in MALDI imaging studies
K Huber, M Aichler, N Sun, A Buck, Z Li, IE Fernandez, SM Hauck, ...
Histochemistry and cell biology 142, 361-371, 2014
Mandates: German Research Foundation
Dosimetry with 188Re-labelled monoclonal anti-CD66 antibodies
G Glatting, T Kull, NM Blumstein, D Bunjes, B Neumaier, AK Buck, ...
Nuklearmedizin-NuclearMedicine 45 (03), 134-138, 2006
Mandates: German Research Foundation
Short Communication: 18F-Immuno-PET: Determination of Anti-CD66 Biodistribution in a Patient with High-Risk Leukemia
B Neumaier, FM Mottaghy, AK Buck, G Glatting, NM Blumstein, B Mahren, ...
Cancer biotherapy & radiopharmaceuticals 23 (6), 819-824, 2008
Mandates: German Research Foundation
Adrenal functional imaging
RA Werner, A Schirbel, AK Buck, M Fassnacht, S Hahner
La Presse Médicale 51 (2), 104114, 2022
Mandates: German Research Foundation
Positron emission tomography and autoradiography imaging of P-selectin activation using 68Ga-fucoidan in photothrombotic stroke
I Israel, F Fluri, A Örbom, F Schadt, AK Buck, S Samnick
Current Neurovascular Research 15 (1), 55-62, 2018
Mandates: German Research Foundation
Complete remission upon peptide receptor radionuclide therapy in a G2 pancreatic neuroendocrine tumor
A Weich, SE Serfling, H Yi, AK Buck, T Higuchi, RA Werner
Clinical Nuclear Medicine 48 (4), 335-336, 2023
Mandates: German Research Foundation
Synthesis and biodistribution of 3′-fluoro-5-[131I] iodo-2′-deoxyuridine: a comparative study of [131I] FLIdU and [18F] FLT
ATJ Vogg, AK Buck, M Schmid, B Neumaier, K Wczasek, BD Zlatopolskiy, ...
Nuclear medicine and biology 34 (3), 273-281, 2007
Mandates: German Research Foundation
Partial response upon peptide receptor radionuclide therapy in a highly proliferative pancreatic neuroendocrine tumor
A Weich, SE Serfling, SP Rowe, LB Solnes, AK Buck, T Higuchi, ...
Clinical nuclear medicine 48 (6), 547-548, 2023
Mandates: German Research Foundation
[18F] FDG-PET/CT improves the detection of synchronous malignancies at primary staging of oral squamous cell carcinoma–A retrospective study
C Linz, RC Brands, S Hackenberg, S Hartmann, T Iring, J Hohm, L Haug, ...
Journal of Cranio-Maxillofacial Surgery 50 (8), 671-676, 2022
Mandates: German Research Foundation
Yingjun Zhi1● Takahiro Higuchi2, 3● Stephan Hackenberg1, 4● Rudolf Hagen1● Manuel Stöth1● Agmal Scherzad1●
AK Buck, RA Werner, SE Serfling
Mandates: German Research Foundation
CXCR4 expression of multiple myeloma as a dynamic process: influence of therapeutic agents
A Bögelein, A Stolzenburg, P Eiring, K Lückerath, U Munawar, R Werner, ...
Leukemia & Lymphoma 63 (10), 2393-2402, 2022
Mandates: Federal Ministry of Education and Research, Germany
Exploring Theranostic Avenues in Adrenocortical Carcinoma Using Chemokine Receptor and Prostate-Specific Membrane Antigen–Directed PET/CT
S Hahner, T Higuchi, SE Serfling, S Samnick, CT Fuss, B Heinze, AK Buck, ...
Clinical Nuclear Medicine, 10.1097, 2022
Mandates: German Research Foundation
Available somewhere: 117
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
JR Dörr, Y Yu, M Milanovic, G Beuster, C Zasada, JHM Däbritz, J Lisec, ...
Nature 501 (7467), 421-425, 2013
Mandates: German Research Foundation
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state
J Den Hollander, S Rimpi, JR Doherty, M Rudelius, A Buck, A Hoellein, ...
Blood, The Journal of the American Society of Hematology 116 (9), 1498-1505, 2010
Mandates: US National Institutes of Health, German Research Foundation, Swedish …
First-in-human experience of CXCR4-directed endoradiotherapy with 177Lu-and 90Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra-and extramedullary …
K Herrmann, M Schottelius, C Lapa, T Osl, A Poschenrieder, H Hänscheid, ...
Journal of nuclear medicine 57 (2), 248-251, 2016
Mandates: German Research Foundation
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
C Bluemel, M Krebs, B Polat, F Linke, M Eiber, S Samnick, C Lapa, ...
Clinical nuclear medicine 41 (7), 515-521, 2016
Mandates: US National Institutes of Health
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
K Philipp‐Abbrederis, K Herrmann, S Knop, M Schottelius, M Eiber, ...
EMBO molecular medicine 7 (4), 477-487, 2015
Mandates: German Research Foundation
Molecular imaging of proliferation in malignant lymphoma
AK Buck, M Bommer, S Stilgenbauer, M Juweid, G Glatting, ...
Cancer research 66 (22), 11055-11061, 2006
Mandates: German Research Foundation
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a …
PM Bath, LJ Woodhouse, JP Appleton, M Beridze, H Christensen, ...
The Lancet 391 (10123), 850-859, 2018
Mandates: British Heart Foundation, National Institute for Health Research, UK
Publication and funding information is determined automatically by a computer program